Olmetec Vs. Atacand Vs. Telmisartan Vs. Irbesartan for a male patient aged 55 - from FDA reports


Summary

This is a personalized comparison Olmetec, Atacand, Telmisartan, Irbesartan for a man aged 55. The study is created by eHealthMe based on reports from FDA.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>



On Aug, 04, 2017

7,968 males aged 55 (±5) who take Olmetec, Atacand, Telmisartan, Irbesartan are studied.

Number of reports submitted per year:

Olmetec, Atacand, Telmisartan, Irbesartan for a male patient aged 55.

Information of the patient in this study:

  • Age: 55
  • Gender: male
  • Reason for the study: Blood Pressure - High

Drugs in this study:

  • Telmisartan (telmisartan)
  • Atacand (candesartan cilexetil)
  • Olmetec (olmesartan medoxomil)
  • Irbesartan (irbesartan)

eHealthMe real world results for males aged 55 (±5):

Most common side effects:

Olmetec:
  • Diarrhea
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Fever
  • Hypotension
  • Nausea
  • Nausea And Vomiting
  • Rashes
  • Weakness
Atacand:
  • Chest Pain
  • Diarrhea
  • Fatigue
  • Fever
  • Hypotension
  • Malaise
  • Nausea
  • Rashes
  • Renal Failure Acute
  • Weakness
Telmisartan:
  • Anaemia
  • Breathing Difficulty
  • Diarrhea
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Hypotension
  • Nausea
  • Rashes
  • Weakness
Irbesartan:
  • Breathing Difficulty
  • Dizziness
  • Drug Ineffective
  • Fatigue
  • Headache
  • Heart Attack
  • Nausea
  • Pain
  • Rashes
  • Weakness

Most common side effects experienced by people in long term use:

Olmetec:
  • Anaemia
  • Diarrhea
  • Dizziness
  • Drug Ineffective
  • Gastroesophageal Reflux Disease
  • Hypotension
  • Malabsorption
  • Nausea And Vomiting
  • Thrombocytopenia
  • Weight Decreased
Atacand:
  • Cerebral Infarction
  • Chest Pain
  • Dizziness
  • Drug Ineffective
  • Hypotension
  • Pleural Effusion
  • Renal Failure Acute
  • Rib Fracture
  • Stress And Anxiety
  • Weakness
Telmisartan:
  • Allergic Rhinitis
  • Chest Pain
  • Dizziness
  • Hyperhidrosis
  • Intervertebral Disc Protrusion
  • Muscle Contractions Involuntary
  • Pharyngitis
  • Pleurisy
  • Pulmonary Mass
  • Renal Impairment
Irbesartan:
  • Arrhythmias
  • Bacteraemia
  • Blood Glucose Increased
  • Breathing Difficulty
  • Death
  • Diabetes
  • Dizziness
  • Musculoskeletal Chest Pain
  • Pancytopenia
  • Pneumonia

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

You can also:

Expand the study to include reports from both FDA and eHealthMe

Expand this study to include FDA and eHealthMe reports

What are the drugs?

Related studies:

Can you answer these questions?

More questions for: Olmetec, Atacand, Telmisartan, Irbesartan

You may be interested in these reviews

More reviews for: Olmetec, Atacand, Telmisartan, Irbesartan